Insider · CIK 0001357522

Thompson Peter A.

Reports to the SEC for 17 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001357522

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-07	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−85.9K sh	$44.86	−$3.85M	2,469,959
2026-06-30	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−116K sh	$45.50	−$5.27M	2,555,877
2026-06-24	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-06-17	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.3K sh	—	—	17,340
2026-06-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+15K sh	—	—	15,000
2026-06-05	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+16.4K sh	—	—	16,377
2026-05-27	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−101 sh	$44.49	−$4,493.49	2,671,721
2026-05-11	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−185K sh	$46.22	−$8.53M	2,671,822
2026-05-08	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−59.8K sh	$44.58	−$2.66M	2,856,461
2026-05-07	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−48.5K sh	$44.61	−$2.17M	2,916,228
2026-04-18	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−2,948 sh	$44.52	−$131K	2,964,774
2026-04-17	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−52.4K sh	$44.68	−$2.34M	2,967,722
2026-04-16	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−227K sh	$45.34	−$10.3M	3,020,119
2026-04-15	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−236K sh	$44.64	−$10.5M	3,247,025
2026-04-14	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−47.8K sh	$44.51	−$2.13M	3,482,888
2026-02-03	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−29.1K sh	$44.58	−$1.3M	3,530,702
2026-02-02	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−1,890 sh	$44.57	−$84.2K	3,559,765
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+30K sh	$15.00	+$450K	30,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$9.70	+$146K	45,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$12.50	+$188K	60,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$3.61	+$54.2K	75,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$2.00	+$30K	90,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$3.27	+$49.1K	105,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$2.74	+$41.1K	120,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$2.60	+$39K	135,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$0.99	+$14.8K	150,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$0.96	+$14.5K	165,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$2.49	+$37.4K	180,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$1.64	+$24.6K	195,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+15K sh	$2.12	+$31.8K	210,000
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−30K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2026-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−15K sh	—	—	0
2025-12-24	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−33.4K sh	$44.55	−$1.49M	3,561,655
2025-12-19	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−875 sh	$44.49	−$38.9K	3,595,011
2025-12-18	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$44.49	−$4,449	3,595,886
2025-12-17	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−900 sh	$44.50	−$40.1K	3,595,986
2025-11-26	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−1,600 sh	$44.49	−$71.2K	3,596,886
2025-11-25	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−11.9K sh	$44.60	−$530K	3,598,486
2025-11-24	SIONSionna Therapeutics, Inc.S Sale	Director	SSale	−94.6K sh	$44.54	−$4.21M	3,610,376

Recent filings

Accepted (ET)
Jul 94
Thompson Peter A.0000947871-26-000695
SEC(opens sec.gov)
Jul 24
Thompson Peter A.0000947871-26-000684
SEC(opens sec.gov)
Jun 264
Thompson Peter A.0001357522-26-000005
SEC(opens sec.gov)
Jun 184
Thompson Peter A.0001357522-26-000003
SEC(opens sec.gov)
Jun 174
Thompson Peter A.0001357522-26-000001
SEC(opens sec.gov)
Jun 154
Thompson Peter A.0001610717-26-000220
SEC(opens sec.gov)
May 294
Thompson Peter A.0000947871-26-000588
SEC(opens sec.gov)
May 114
Thompson Peter A.0000947871-26-000518
SEC(opens sec.gov)
Apr 214
Thompson Peter A.0000947871-26-000459
SEC(opens sec.gov)
Apr 164
Thompson Peter A.0000947871-26-000447
SEC(opens sec.gov)
Feb 44
Thompson Peter A.0000947871-26-000089
SEC(opens sec.gov)
Jan 304
Thompson Peter A.0000947871-26-000079
SEC(opens sec.gov)

Companies

Address

C/O SIONNA THERAPEUTICS, INC. 21 HICKORY DRIVE, SUITE 500

WALTHAM, MA, 02451